Skip to main content

Table 1 Twenty-three features of COVID-19 patients in the cohort

From: Comparing different machine learning techniques for predicting COVID-19 severity

Variables

All cases

Non-severe cases

Severe cases

P

(n = 287)

(n = 182)

(n = 105)

Fever

88 (30.7)

57 (31.3)

31 (29.5)

0.751

MT

16 (5.6)

11 (6.0)

5 (4.8)

0.648

HR, beats/min

88 (80–99)

87 (80–98)

88 (84–99)

0.122

SBP, mmHg

127 (117–138)

125 (115–136)

131 (121–138)

0.008

Laboratory findings

    

 NLR

3.28 (2.17–5.77)

2.71 (1.70–4.15)

5.73 (3.17–9.97)

 < 0.001

 HB

127.0 (117.0–136.0)

128.0 (119.0–136.0)

123 (114.0–136.0)

0.109

 RDW-CV

12.4 (11.9–12.9)

12.3 (11.9–12.8)

12.5 (11.9–13.0)

0.032

 LDH

258.0 (200.0–346.5)

231.0 (184.7–276.5)

343.0 (261.0–452.0)

 < 0.001

 IBIL

8.4 (6.1–11.6)

8.9 (6.6–11.8)

7.8 (5.6–10.80)

0.048

 D-Dimer

0.7 (0.4–1.5)

0.5 (0.3–0.9)

1.1 (0.6–1.5)

 < 0.001

 PT

11.3 (10.7–12.0)

11.2 (10.6–11.7)

11.7 (10.8–12.6)

 < 0.001

 Ca2+

2.10 (1.99–2.17)

2.09 (22.0–52.25)

2.01 (1.93–2.10)

 < 0.001

 ESR

43.0 ( (26.0–58.0)

40.5 (18.0–27.0)

50.3 (35.0–65.5)

 < 0.001

 AFU

23.0 (19.0–27.0)

23.0 (18.0–27.0)

23.0 (20.0–27.0)

0.508

 RBP

26.4 (19.0–40.4)

26.4 (20.6–40.5)

26.4 (17.1–40.0)

0.433

 IL-6

8.3 (6.5–11.7)

8.2 (6.5–10.2)

9.2 (7.2–12.9)

0.001

 Hs-cTn

3.6 (1.5–8.3)

2.9 (1.1–5.8)

6.2 (2.8–12.4)

 < 0.001

 AMS

62.0 (49.0–79.5)

62.0 (49.3–74.0)

68.0 (49.0–97.0)

0.078

 CysC

0.85 (0.75–1.03)

0.83 (0.73–0.94)

0.95 (0.78–1.16)

 < 0.001

 IMG

0.01 (0.01–0.04)

0.01 (0.00–0.03)

0.03 (0.01–0.11)

 < 0.001

 ALP

76.0 (59.5–94.0)

76.0 (59.3–95.8)

75.0 (60.0–93.0)

0.806

 MB

42.4 (30.7–64.5)

39.1 (28.0–53.0)

50.1 (38.8–87.3)

 < 0.001

C-CTa

   

 < 0.001

 0

63 (22.0%)

63 (34.6%)

0 (0%)

 

 1

29 (10.1%)

23 (12.6%)

6 (5.7%)

 

 2

195 (67.9%)

96 (52.7%)

99 (94.3%)

 
  1. Data were presented median (IQR) or n (%). P values were estimated by comparing variables between severe and non-severe cases
  2. a“0” denotes” no lung lesions”, “1” denotes “unilateral lung lesions”, and “2” denotes “bilateral lung lesions”
  3. MT Malignant tumor, HR Heart rate, SBP Systolic blood pressure, NLR Neutrophil-to-lymphocyte ratio, HB Hemoglobin concentration, RDW-CV Red cell volume distribution width, LDH Lactate dehydrogenase, IBIL Indirect bilirubin, PT Prothrombin time, ESR Erythrocyte sedimentation rate, AFU α-fucosidase, RBP Retinol-Binding protein, IL-6 Interleukin-6, Hs-cTn Hypersensitive troponin, AMS Amylase, CysC cystatin C, IMG Immature granulocyte, ALP Alkaline phosphatas, MB Myoglobin, C-CT Chest computed tomography
Back to article page

Infectious Diseases of Poverty

ISSN: 2049-9957

Contact us